NaturalPedia > Eli Lilly

Quotes about Eli Lilly from the world's top natural health / natural living authors

 Email this page to a friend   |  Click here for FREE email alerts

page 2 of 6 | Next ->

"Eli Lilly, the maker of Prozac, has data showing that 38 percent of people who take the drug become "activated," a term that includes varying degrees of agitation. But those data are considered "proprietary," and they have surfaced only once during a court case before a judge ordered them sealed. pediatric prescriptions for antipsychotics, powerful drugs that were developed to treat such serious psychiatric conditions as schizophrenia, mania, and bipolar disorder. Psychiatric visits that included treatment of a child with an antipsychotic went from a little over 200,000 in 1993 to 1." - Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (Get the book.)

"In fact, eli lilly, the maker of the antipsychotic drug called Zyprexa, has already paid $1.2 billion to settle thirty thousand lawsuits from people who claim that Zyprexa caused them to develop diabetes or other diseases, and is also alleged to have promoted Zyprexa for unapproved off-label use, which it denies. Drug companies cannot actively promote drugs for off-label uses, but doctors can prescribe them for such uses. (For example, Zyprexa is approved for schizophrenia but doctors also prescribe it for anxiety." - Mark Hyman MD, The UltraMind Solution: Fix Your Broken Brain by Healing Your Body First (Get the book.)

"With the help of eli lilly, the young anglers were learning everything they needed to catch the big fish and then relax, like the pros. Back at the Quad Cities golf tournament, Cialis was not the only prescription drug being promoted. At the eighteenth hole, men and women sat behind a white picket fence, sipped their Bud Lights (a tournament sponsor), and watched J. S. Lewis sink his last putt of the day to win the Crestor Charity Challenge. Drugmaker AstraZeneca had created the contest to promote its new cholesterol pill, Crestor. The name of the contest was brilliant." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"In late 2006, a scandal erupted when a plaintiff's lawyer from Alaska sent internal company documents obtained during a court case against eli lilly, the maker of Zyprexa, to a reporter at the New York Times. The newspaper reported that the documents, which included e-mail, marketing material, sales projections, and scientific reports, showed that the company had hidden information about the drug's potential to cause severe side effects." - Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (Get the book.)

"For example, eli lilly thought it had a real winner in 2001 when the FDA approved Xigris. This breakthrough high-tech drug had been shown to improve the survival rate of people who were critically ill with septic shock—an extremely serious condition caused by bacterial infection in the bloodstream, which is responsible for 225,000 deaths in the United States each year. The New England Journal of Medicine published a report in 2001 showing that Xigris decreased the mortality rate from this dreaded condition by 6.1 percent, saving the life of 1 out of every 16 patients treated." - John Abramson, Overdosed America: The Broken Promise of American Medicine (P.S.) (Get the book.)

"Among his new clients were PhRMA, Pfizer, eli lilly and Merck. Linda Fishman, from the majority side of the Finance Committee, left to become a lobbyist with the drug manufacturer Amgen. Pat Morrisey, chief of staff of the Energy and Commerce Committee, took a job lobbying for drug companies Novartis and Hoffman-La Roche. Jeremy Allen went to Johnson and Johnson. Kathleen Weldon went to lobby for Biogen, a Bio-tech company. Jim Barnette left to lobby for Hoffman-La Roche." - Jonathan W. Emord, The Rise of Tyranny (Get the book.)

"When the authors of the Journal of Psychiatry survey looked at the trials, they found a curious thing: In five trials that were paid for by eli lilly, its drug, Zyprexa, came out looking superior to Risperdal, a drug made by the company Janssen. But when Janssen sponsored its own trials, Risperdal was the winner three out of four times. When it was Pfizer funding the studies, its drug, Geodon, was best. In fact, this tendency for the sponsor's drug to come out on top held true for 90 percent of the more than thirty trials in the survey." - Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (Get the book.) "Premenstrual dysphoric disorder, for instance, made its way into the psychiatric manual in 1999 largely as the result of behind-the-scenes efforts by eli lilly, the manufacturer of Serafem, a repackaged version of Prozac that the company wanted to market for premenstrual symptoms. The pharmaceutical industry has pushed new diagnostic categories in other medical arenas, and it has helped broaden the definitions of risk factors that can be treated with drugs." - Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (Get the book.)

"The others soon followed, as eli lilly experienced such success with Prozac? the profit potential was obvious. This was especially apparent when, at a conference in Anaheim California that I attended several years ago. Dr. Ann Blake Tracy indicated that since the 9/11 incident, one in dVz people in the nation were on antidepressants. As Prozac?was the first announced SSRI antidepressant, it is the best known. I don't want you, or the maker of Prozac?(Eli Lilly), to think that I am picking on Prozac? or that it is the only SSRI antidepressant involved in suppressing the thyroid." - Dr. David W. Tanton; Ph.D., A Drug-Free Approach To Healthcare, Revised Edition (Get the book.)

"Mississippi, Louisiana, Alaska and West Virginia sued eli lilly & Co. this year on behalf of their Medicaid health programs for the poor. They said the company fraudulently touted the antipsychotic Zyprexa for unapproved uses. Indianapolis-based Lilly settled about eight thousand personal-injury complaints for $700 million in 2005 and faces four thousand more claims. We are a drug-addicted society, and we are overprescribed medication when there are better solutions." - Mark Hyman MD, The UltraMind Solution: Fix Your Broken Brain by Healing Your Body First (Get the book.)

"David Wong, other members of the eli lilly Company research team, also received the awards. It took two years before Prozac became widely prescribed, but by 1995 the annual sales were up to $2.07 billion. That was nearly one third of Lilly's total annual sales! But that wasn't even the peak of its sales. In 2000, it peaked at $3 billion. It had become the popular wonder drug prevalent in the 21st century.190 And it was no wonder! Prozac promised happiness in a bottle." - Kenneth W Thomas, Ron Gilbert, Gerd Schaller, Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel (Get the book.) "Zoloft also has been blamed for causing suicidal behavior, and there are over 200 lawsuits filed against Pfizer, eli lilly and GlaxoKlineSmith because of this drug.209 Two hundred! And still the pharmaceutical companies adamantly insisted it was not the fault of the drug. Effexor XR has other side effects as well as hostility, agitation and restlessness. It can raise blood pressure. And Wellbutrin can also raise blood pressure and can bring on seizures, not to mention other disturbing side effects.210 And yet the money keeps pouring in from the sales of these drugs. 208 http://vvww." - Kenneth W Thomas, Ron Gilbert, Gerd Schaller, Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel (Get the book.)

"The chief of Eli Lilly: "The potential pressures of public advertising of prescription drugs on the scientific decisions of the physician are both unwise and inappropriate." The head of Johnson and Johnson: "[DTC] could adversely affect the traditional patient-physician relationship. Physicians might find themselves having to defend their choice of what they consider an appropriate medication simply because the chosen drug is not heavily advertised and not familiar to the consumer . . ." - Greg Critser, Generation Rx: How Prescription Drugs are Altering American Lives, Minds, and Bodies (Get the book.)

"On New Year's Day 2005, the BMJ published an article by Jeanne Lenzer which indicated that eli lilly, the maker of Prozac, had failed to disclose documents during a lawsuit that found Prozac could increase the risk of aggressive behavior and suicide.1 Overnight tens of millions heard the story as the report was passed along by the news media. The implications for Lilly were horrendous. Lawsuits are often won or lost based on public attitudes and perceptions. Suddenly Lilly was at lawsuit risk for the thousands of Prozac patients who had committed suicide." - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"In November 1993, a group of investigators, supported in part by the eli lilly pharmaceutical company, estimated "that the annual costs of depression in the United States total approximately $43.7 billion."3 Mental health advocates frequently cite this figure and others like it, as if it proved that depression is a disease. For instance, Tipper Gore, mental health advisor to President Clinton's Health Care Task Force, asserts that "depression alone costs society $43.7 billion annually . . ." - Thomas Szasz, The Medicalization of Everyday Life: Selected Essays (Get the book.)

"Eli Lilly.3 literature. So where do they get their knowledge about new drugs? Listen closely to Dr. Avorn's amazing conclusion: Pharmaceutical marketing is about the most important source of knowledge about new drugs for most physicians, and a major form of continuing conditioning as well.43 That is an absolutely startling admission, but perhaps we should not be surprised since the physician-industry relationship is established so early. During medical school students are showered with free gifts from the drug industry." - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.) "The nervous system effects which occur frequently (again, this is as reported by eli lilly, the maker of Prozac) include (1) agitation (Definition: extreme emotional disturbance3), (2) amnesia (Definition: partial or total loss of memory), (3) confusion (Definition: impaired orientation with respect to time, place or person) and (4) emotional lability (Definition: not listed in my dictionary, so I tried the Webster s New World Medical Dictionary and found it defined as "susceptible to change, error or instability." It comes from the Latin word labilis which means "prone to slip."" - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"It is particularly disturbing that eli lilly, the manufacturer, went on to promote the drug for use in children with full knowledge of these facts. Why are dangerous drugs allowed into the marketplace? Pharmaceutical companies control the flow of information to the extent that they can tilt decision-making so that substances with no proven benefits, yet significant risks, are allowed on the market, to be dispensed by physicians operating with misleading and incomplete information." - Fred A. Baughman, Jr., M.D. and Craig Hovey, The ADHD Fraud: How Psychiatry Makes "Patients" of Normal Children (Get the book.)

"Prozac was drawing in users at an unprecedented rate for a modern pharmaceutical at that time, and the fortunes of eli lilly, the company that made it, were inextricably linked to the drug's fate. Projections at the time of the trial were that [Prozac] would earn Lilly $1.7 billion in 1995, accounting for almost a third of its revenues. 'Winning the case convincingly would give Lilly a powerful promotional gambit to demonstrate to the world that the drug stood vindicated by jury verdict,' wrote Cornwell. 'The consequences of a loss, on the other hand, could be catastrophic." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.)

"In 2002, Eli Lilly's drug Strattera (atomoxetine hydrochloride) became the first drug specifically approved and promoted for the treatment of ADHD in adults (see www.strattera.com/1_4_adult_adhd/1_4_adult.jsp). Lilly started a marketing campaign that included television commercials to make the public more aware of adult ADHD. The ads depicted a distracted man forgetting his car keys, arriving late for appointments, and unable to complete work assignments on time, implying that these were symptoms of adult ADHD." - Peter Conrad, The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders (Get the book.) "A relatively limited number of potentially short children were treated with Protropin, but the number is apt to grow because the FDA recently approved an eli lilly growth hormone, Humatrope, for use for short-statured children in the shortest 1.2 percent of the population. This is a potential market of 400,000 children. Ironically, as more children are treated and grow beyond the shortest 1.2 percent line, others will drop below this percentage threshold, thus creating an increasing pool of eligible children, beyond the 400,000 originally estimated." - Peter Conrad, The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders (Get the book.)

"And it only came to light in a case brought about by two pharma companies, eli lilly and Icos, that had teamed up to form a joint venture to develop Cialis, the so-called 'weekend' answer to Viagra. The case hardly raised a mention in the mainstream press, but it explains the intense battle we now see between broadly similar products fighting for a slice of the growing erectile dysfunction market. The science, how the PDE-5 inhibitors work, had apparently been sufficiently written up in the medical literature to strip Pfizer of its 20-year monopoly on how that science is deployed." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.)

"No one could say that about Eli Lilly's clinical trials for Cym-balta, or duloxetine, its successor to Prozac. For years, Lilly had been testing it in some of the most secure, well-funded research centers in the world. By 2003, Lilly was so assured of the drug's impending approval that it hired a powerful New York public relations firm just to walk the aisles of the annual convention of the American Psychiatric Association and hand out the results of the studies." - Greg Critser, Generation Rx: How Prescription Drugs are Altering American Lives, Minds, and Bodies (Get the book.)

"The 1988 eli lilly document indicated that 3.7 percent of patients attempted suicide while on Prozac, a rate more than 12 times that cited for any of four other commonly used antidepressants. The document, which cited clinical trials of 14,198 patients on fluoxetine, the generic name for Prozac, also stated that 2.3 percent of users suffered psychotic depression while on the drug. This was more than double the next-highest rate for patients using another antidepressant. In addition, the paper noted that 1." - Andreas Moritz, Timeless Secrets of Health & Rejuvenation: Unleash The Natural Healing Power That Lies Dormant Within You (Get the book.) "On January 2, 2005, CNN reported that an internal document purportedly from eli lilly and Co. revealed that the drug maker had data more than 15 years ago showing that patients on its antidepressant, Prozac, were far more likely to attempt suicide and show hostility than were patients on other antidepressants. For obvious reasons, the company attempted to minimize public awareness of the drug's side effects. The document was provided to CNN by the office of Rep. Maurice Hinchey, D-New York, who has called for tightening FDA regulations on drug safety. " - Andreas Moritz, Timeless Secrets of Health & Rejuvenation: Unleash The Natural Healing Power That Lies Dormant Within You (Get the book.)

"Federal Investigations In 1994 several federal agencies began a series of investigations targeting eli lilly and Genentech for overpromoting their growth hormone products—that is, marketing them for nonapproved uses (R. Weiss, 1993; Mintz, 1995; Auerbach, 1996; Amoroso, 1999).2 Initial interest was stimulated by a New York Times article that appeared in June 1991 (Werth, 1991), prompting an FDA inspection in 1992." - Peter Conrad, The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders (Get the book.) "In July 2003 the FDA approved the use of Humatrope, an eli lilly version of hGH, to treat the shortest 1.2 percent of children with ISS. This was the first official approval of a drug to treat short children who did not have a growth hormone deficiency. As part of the approval, Lilly agreed not to advertise directly to consumers. The company estimates that 400,000 children could fit this new criterion, although only an expected 10 percent would get treatment (M. Kaufman, 2003)." - Peter Conrad, The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders (Get the book.)

"Strattera from Eli Lilly; (2) the SSRI antidepressants Prozac, Paxil, Zoloft, Lexa-pro, Celexa, etc.; (3) the tricyclic and heterocyclic antidepressants Tofranil, Norpramin (desipramine), Elavil, Desyrel, Sinequan, Vivactil, Surmontil etc.; (4) atypical antidepressants—Effexor, Wellbutrin; (5) anticonvulsants (Depakote, Depakene, Tegretol, Neurontin, Topamax, etc.); and (6) antipsychotics (Thorazine, Mellaril, Risperdal, Seroquel, Abilify, Clozapine, Clozaril, Ge-odon, Haldol, Loxitane, Navane, Orap, Zyprexa, etc.)." - Fred A. Baughman, Jr., M.D. and Craig Hovey, The ADHD Fraud: How Psychiatry Makes "Patients" of Normal Children (Get the book.)

"There have been anecdotal reports of people not being able to use Eli Lilly's human insulin. Switching to NovoNordisk's composition of human insulin allayed the problem. Did the patent examiner know that by-products related to these two production methods would possibly be contained in the end product? You, the juror, must consider that the human body is the ultimate biological test equipment; if differences exist some individuals will detect those differences." - Brent Hoadley, Ph.D., Too Profitable to Cure (Get the book.)

"Vinblastine is marketed as Velbe by eli lilly and is useful for treating Hodgkin's disease, lymphomas. oh n ^C02ch3 H3C0A2 n—v bW r" h " A>ch3 >~~\ P ho ¦, \^ C02ch3 nch3 Vincristine, R = CHO Vinblastine, R = CH3 advanced testicular cancer, advanced breast cancer and Kaposi's sarcoma. This drug has a number of side effects, including hair loss, nausea, lowered blood cell counts, constipation and mouth sores. Vincristine is marketed as Oncovin by eli lilly and is used to treat acute leukaemia, Hodgkin's disease and other lymphomas." - Dr. Michael Heinrich, Joanne Barnes, Simon Gibbons and Elizabeth M. Williamson, Fundamentals of Pharmacognosy and Phytotherapy (Get the book.)

page 2 of 6 | Next ->

FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.

TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalPedia.com

This unique compilation of research is copyright (c) 2008, 2009 by the non-profit Consumer Wellness Center.

ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of NaturalPedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.